Abstract:Cancer patients' symptom experiences are complex and exhibit a large amount of interindividual variability. This clinical reality poses major challenges in the prioritization of symptom management interventions. This study is the first to use computational network analysis and unsupervised clustering approaches with a sample of 3088 cancer patients to model symptom interconnectedness, group patients based on shared symptom patterns, and identify core symptoms to target in each group. Background Interindividual variability in oncology patients' symptom experiences poses significant challenges in prioritizing symptoms for targeted intervention(s). In this study, computational approaches were used to unbiasedly characterize the heterogeneity of the symptom experience of oncology patients to elucidate symptom patterns and drivers of symptom burden. Methods Severity ratings for 32 symptoms on the Memorial Symptom Assessment Scale from 3088 oncology patients were analyzed. Gaussian Graphical Model symptom networks were constructed for the entire cohort and patient subgroups identified through unsupervised clustering of symptom co‐severity patterns. Network characteristics were analyzed and compared using permutation‐based statistical tests. Differences in demographic and clinical characteristics between subgroups were assessed using multinomial logistic regression. Results Network analysis of the entire cohort revealed three symptom clusters: constitutional, gastrointestinal‐epithelial, and psychological. Lack of energy was identified as central to the network which suggests that it plays a pivotal role in patients' overall symptom experience. Unsupervised clustering of patients based on shared symptom co‐severity patterns identified six patient subgroups with distinct symptom patterns and demographic and clinical characteristics. The centrality of individual symptoms across the subgroup networks differed which suggests that different symptoms need to be prioritized for treatment within each subgroup. Age, treatment status, and performance status were the strongest determinants of subgroup membership. Conclusions Computational approaches that combine unbiased stratification of patients and in‐depth modeling of symptom relationships can capture the heterogeneity in patients' symptom experiences. When validated, the core symptoms for each of the subgroups and the associated clinical determinants may inform precision‐based symptom management.

The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis

Multiple myeloma patients undergoing chemotherapy: Which symptom clusters impact quality of life?

[A Multi-Centers Clinical Study of Different Treatment Outcomes of 332 Patients with Multiple Myeloma].

Identifying Central Symptom Clusters and Correlates in Patients with Lung Cancer Post-Chemotherapy: A Network Analysis

Contemporaneous symptom networks analysis in lymphoma patients during chemotherapy: protocol for a single-centre prospective cross-sectional study

Symptom clusters and quality of life in ambulatory patients with multiple myeloma

Network Analysis of the Multidimensional Symptom Experience of Oncology

Symptom Network Analysis and Unsupervised Clustering of Oncology Patients Identifies Drivers of Symptom Burden and Patient Subgroups With Distinct Symptom Patterns

Exploring Central and Bridge Symptoms in Patients with Lung Cancer: A Network Analysis

Classification of symptom subtypes in patients with multiple myeloma during treatment: a cross-sectional survey study in China.

Chemotherapy-related symptoms in children with leukemia: application of latent profile analysis and network analysis

Symptom Networks in Older Adults with Cancer: A Network Analysis.

Symptom cluster study undergoing chemotherapy in breast cancer patients: Latent class analysis and contemporaneous network analysis

Symptom experiences and self-management strategies of patients with haematological malignancy undergoing chemotherapy: A qualitative study

A Network Analysis of Multiple Myeloma Related Gene Signatures.

Symptom clusters and symptom network analysis during immunotherapy in lung cancer patients

Symptom experience and response of multiple myeloma patients based on symptom management theory model:a qualitative study

Symptoms of Hematologic Tumors Patients after CAR-T Therapy: a Systematic Review and Meta-Analysis

Changes in immune subsets during chemotherapy as prognosis biomarkers for multiple myeloma patients by longitudinal monitoring

Features and Differences in Core Symptom Clusters in Home‐Based Hospice Patients With Advanced Cancer: A Network Analysis

The connections of physical and psychosocial symptoms among patients with terminal illnesses: A network analysis